Migraine: one of the most disabling diseases on the planet.

It’s not just about the pain. Symptoms like nausea and sensitivity to light or sound can make it impossible to do anything. And if you suffer from chronic migraines, you likely spend a lot of time each month in the throes of a migraine.

It’s extremely isolating. Chronic migraines can keep you from work or school, interfere with your relationships, and lower your self-esteem. People who don’t have migraines often just don’t get it. If you feel like there’s a stigma around your chronic migraine, you’re not alone.

New prevention options needed. Migraines differ from person to person—and so can their treatment. It can be challenging to find something that works. This is why researchers are conducting a clinical trial to evaluate whether a study drug works against chronic migraine.

Take the next step to see if you qualify for local research studies for people with migraine.

Get started now

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exam rooms thoroughly between every patient visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.